Acquiring Company
Merck
Description
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Acceleron Pharma Inc. (Nasdaq: XLRN), a publicly traded biopharmaceutical company, today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Acceleron for $180 per share in cash for an approximate total equity value of $11.5 billion.
Other recent acquisitions in Healthcare and Manufacturing
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Strongbridge Biopharma Plc Announces Court Hearing Date To Approve Proposed Acquisition By Xeris Pharmaceuticals, Inc. (September 23, 2021)
- Strongbridge Biopharma Plc Announces Shareholder Approval Of Proposed Acquisition By Xeris Pharmaceuticals, Inc. (September 8, 2021)
- Labcorp Completes Acquisition Of Myriad Autoimmune’S Vectra Testing Business (September 13, 2021)
- Labcorp Completes Acquisition Of Myriad Autoimmune’S Vectra Testing Business (September 13, 2021)
- 23Andme Announces The Closing Of Its Acquisition Of Lemonaid Health (November 1, 2021)
- Picard Medical, Inc. Acquires Mechanical Heart Replacement Technology (September 30, 2021)
Who to call at Merck, and when
When Merck changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Merck raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Merck, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Merck. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Merck makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.